-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Reels
-
Blogs
-
Offres
-
Emplois
Iridex Corporation is a globally recognized medical technology company specializing in advanced ophthalmic laser systems and medical devices for eye care professionals. Serving hospitals and clinics worldwide, their solutions support the treatment of retinal diseases and glaucoma with precision and reliability. Located at 1212 Terra Bella Ave, Mountain View, CA 94043, United States, Iridex Corporation is known for innovation and clinical excellence. For more information, call +1 650-940-4700 or visit their website for trusted ophthalmic solutions.
-
3 Articles
-
2 Photos
-
0 Vidéos
-
Iridex Corporation à Mountain View
-
Habitant Mountain View
-
Du California
-
Étudié Mountain View à Mountain View
-
Male
-
Suivi par 0 membre
Mises à jour récentes
-
0 Commentaires 0 Parts 2 Vue 0 AperçuConnectez-vous pour aimer, partager et commenter!
-
Laser Therapy for Diabetic Retinopathy
Interested in effective laser therapy for diabetic retinopathy management? Iridex Corporation offers advanced ophthalmic laser systems designed to support retinal specialists in treating diabetic eye conditions. Our technology delivers precision and reliability for retinal procedures, helping clinicians provide targeted care, preserve vision, and achieve consistent treatment outcomes while addressing the challenges associated with diabetic retinopathy.
https://www.iridex.com/Products/Lasers/IQ532.aspxLaser Therapy for Diabetic Retinopathy Interested in effective laser therapy for diabetic retinopathy management? Iridex Corporation offers advanced ophthalmic laser systems designed to support retinal specialists in treating diabetic eye conditions. Our technology delivers precision and reliability for retinal procedures, helping clinicians provide targeted care, preserve vision, and achieve consistent treatment outcomes while addressing the challenges associated with diabetic retinopathy. https://www.iridex.com/Products/Lasers/IQ532.aspx0 Commentaires 0 Parts 6 Vue 0 Aperçu -
0 Commentaires 0 Parts 3 Vue 0 Aperçu
Plus de lecture